Personality Disorders
Feature
Psychiatric genomics has a diversity problem
For a long time researchers thought including “multiple ancestries in first rounds of genetic analyses” was too complicated, said Dr. Laramie...
Evidence-Based Reviews
Managing ‘difficult’ patient encounters
Recognize and address the 3 types of contributing factors: The patient, the physician, and the system.
Feature
APA, AMA, others move to stop insurer from overturning mental health claims ruling
The APA hopes that whatever the court says about United Behavioral Health applies to all insurers that provide employer-sponsored health benefits...
From the Journals
Prevalence of psychiatric disorders higher in adult cerebral palsy patients
“The present study contributes important information to the existing literature, highlighting that psychiatric issues are common in adults with [...
From the Journals
Two key suicide risk factors identified in borderline personality disorder
Clinicians should query patients about “longstanding” feelings of emptiness, said Dr. Carlos M. Grilo.
Commentary
Contradictions abound in ‘The End of Mental Illness’
Dr. Daniel G. Amen’s book made him think and reflect upon his own practice, said Dr. Samuel R. Weber.
Feature
Borderline personality disorder diagnosis: To tell or not to tell patients?
Not disclosing a diagnosis "is like you're not trusting a patient to be a reasonable adult human about this," said Dr. Amy Barnhorst.
Evidence-Based Reviews
A clinical approach to pharmacotherapy for personality disorders
Evidence is limited, but these principles and strategies can help guide prescribing.
Conference Coverage
When should a patient’s violent thoughts trigger your action?
A good violence risk assessment can help you mitigate the potential for one of your patients to carry out harm to self or to others.
Conference Coverage
Aggression is influenced by genetic, environmental factors
"What we think is that the threshold to explode is probably regulated by various neurobiological features," said Dr. Emil F. Coccaro.
Conference Coverage
Novel drug may lower agitation, aggression in multiple psychiatric disorders
The study “supports vafidemstat as an emerging therapeutic option to treat aggression-agitation,” said Dr. Roger Bullock.